請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/45257
標題: | Globo-H 結合對硝基苯作為抗癌症疫苗的研究 Study of anti cancer vaccine by using Globo H combined with p-nitrophenyl group |
作者: | Hsin-Yu Lee 李信佑 |
指導教授: | 翁啟惠(Chi-Huey Wong) |
共同指導教授: | 吳宗益(Chung-Yi Wu) |
關鍵字: | 乳癌,疫苗,醣脂質,佐劑,醣抗原, breast cancer,vaccine,glycolipid,adjuvants,Globo H, |
出版年 : | 2010 |
學位: | 碩士 |
摘要: | 大部分癌症細胞表面會表現多量的特定醣抗原,Globo H (Fucα1→2Galβ1→ 3GalNAcβ1→ 3Galα1→4Galβ1→ 4Glc)六碳醣是其中一種,它高度表現在乳癌、前列腺癌、卵巢癌、胰腺癌、大腸直腸癌及肺癌之細胞表面。Danishefsky的研究發現Globo H接上KLH蛋白當作疫苗可以產上抗體專一性的針對癌細胞,另外Schultz證明將蛋白質之某一個酪氨酸(Tyr)置換成對硝基苯丙氨酸(pNO2Phe)產生高表現量的抗體,且此抗體亦可針對未突變的蛋白。因此本篇的目標是結合Globo H及pNO2Phe為特別的醣抗原,接上牛血清白蛋白(BSA)當作抗癌疫苗(GHN-BSA),和Globo H直接接上牛血清蛋白結合的抗癌疫苗(GH-BSA)作比較,預期GHN-BSA可以產生高表現量抗體辨認Globo H醣抗原。由動物實驗的結果顯示GHN-BSA產生高表現量的抗體,可惜此沒有辨認Globo H醣抗原,而是辨認pNO2Phe,而由GH-BSA可以產生專一性辨認Globo H的抗體。我們推論因對硝基苯是強烈的免疫抗原,而設計之疫苗上Globo H及pNO2Phe在GHN-BSA占有相同的比例,導致結果不如預期,假如修改其之間的比例或許可以產生高表現的抗體專一性辨認Globo H醣抗原,下一代的GHN-BSA疫苗使用不同的連結方式來提升Globo H和pNO2Phe的比例至5.14/1.36,且動物實驗正要進行,希望可以得到預期的效果。 Most of the cancer cells expressed large amounts of carbohydrate antigens on the cell surface. For example, an antigenic hexasaccharide, Globo H (Fucα1→2Galβ1→ 3GalNAcβ1 → 3Galα1→4Galβ1→4Glc), is overexpressed in surfaces of many human cancers, including breast, prostate, ovary, pancreas, colon and lung cancers. It was previously demonstrated that BSA-conjugated Globo H(GH-BSA) adjuvanted with α-GalCer can induce Globo H-specific antibodies. Another study led by Schultz showed that the incorporation of a p-nitrophenylalanine onto TNF can induce a potent antibody response in mice. Herein, we further linked Globo H to p-nitrophenyl group and the resulting unit was conjugated to BSA (GHN-BSA) and explored its immune-eliciting ability as a cancer vaccine. Animal experiments showed that antibodies induced by GHN-BSA vaccine recognized the p-nitrophenyl group but not Globo H carbohydrate antigen. On the other hand, antibodies induced by GH-BSA vaccine recognize Globo H and analogues. We hypothesized that since the p-nitrophenyl group is a strong immunogen and Globo H is a weak one, the same proportion of Globo H to pNO2Phe in the vaccine candidate GHN-BSA would lead to much more antibodies for pNO2Phe. Hence, a new generation of GHN-BSA vaccine with ratio of Globo H over pNO2Phe is 3.78 was synthesized and immunization experiments are ongoing. We wished that raising the ratio of Globo H over pNO2Phe may be able to enhance antibodies specifically to recognize Globo H antigen. |
URI: | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/45257 |
全文授權: | 有償授權 |
顯示於系所單位: | 化學系 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-99-1.pdf 目前未授權公開取用 | 4.39 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。